Centre Approved Anti Viral Medicines To Treat Covid 19 Patients, Says SC

Brazil Approves RedHill Biopharma’s Phase 2/3 COVID-19 Study with Opaganib

TEL AVIV, Israel and RALEIGH, N.C., Sept. 22, 2020 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, today announced approv ...

CookieConsent124 Moneyspecial Um diese Cookiebar auszublenden. 1 Jahr http Infront Financial Technology GmbH

Boehringer Ingelheim and Mirati Therapeutics, Inc. (NASDAQ: MRTX) today announced a clinical collaboration to evaluate the combination of BI 1701963, a SOS1::pan-KRAS inhibitor blocking KRAS independe ...

Avigan® Shows Promising Results in Treatment of COVID Patients in Japan

Avigan® Tablet was approved for manufacture and sale in Japan in 2014 as an influenza anti-viral drug. The drug is to be ...

Novus Therapeutics Announces Acquisition of Anelixis Therapeutics

Novus Therapeutics, Inc. ("Novus”) (NASDAQ: NVUS) today announced it has completed the acquisition of Anelixis Therapeutics, Inc. ("Anelixis”), a privately held clinical stage biotechnology company de ...

Marinus Provides Corporate Update on Phase 3 RAISE Trial in Status Epilepticus (SE)

In July, Marinus submitted a protocol amendment to the FDA for the RAISE trial for IV ganaxolone in RSE. Following a recent FDA discussion, Marinus currently anticipates the first patient will be enro ...

en_USEnglish
en_GBEnglish (UK) en_USEnglish